comprehensive -WSS

comprehensive

author：entertainment 2025-09-27 06:09:35 - browse：37

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Empower primary care with adequate payments and technology

leisure time

WSS

Brain technologies pose threats that are all too real, experts warn

In his State of the Union, Biden takes clear aim at 'Big Pharma'

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Can gargling with Listerine treat gonorrhea of the mouth?

Brain technologies pose threats that are all too real, experts warn

RSV shot was 90% effective at preventing hospitalizations in kids

leisure time

comprehensive

explore

Heart attack and stroke risk calculators need revising

In his State of the Union, Biden takes clear aim at 'Big Pharma'

United colonoscopy coverage change 'may cost lives,' doctors say

Brain technologies pose threats that are all too real, experts warn

DIEP, the 'gold standard' of breast reconstruction, is under threat

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Hepatitis C has a cure — but many Americans still lack access to it

AltruBio raises $225 million to develop ulcerative colitis drug

Cancer drug shortages should be causing more outrage

Change Healthcare payments predicted restored March 15

leisure time

The problem with charging patients to message their doctors

Primary care doctor shortage won't be solved by free med school tuition

Class action alleges UnitedHealth concealed DOJ probe

Warren pushes Witty on UnitedHealth's control over physicians

Change Healthcare cyberattack prompts Medicare loan program

PBM executives asked to testify by House panel

hotspot

knowledge

leisure time

focus